Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Gustafsson, Rasmus K L ^a   Engdahl, Elin E ^a   Hammarfjord, Oscar ^a   Adikari, Sanjaya B ^b   Lourda, Magda ^a,c   Klingström, Jonas ^a,d   Svensson, Mattias ^a   Fogdell Hahn, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 8;

ADAPTIVE IMMUNITY; ARTICLE; AUTOCRINE EFFECT; CELL ISOLATION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN HERPESVIRUS 6; INNATE IMMUNITY; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; VIRUS REPLICATION;

ADAPTIVE IMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; HERPESVIRUS 6, HUMAN; HLA ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERFERON-ALPHA; INTERLEUKIN-4; VIRUS REPLICATION;

EID: 84874638025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058122     Document Type: Article

References (36)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, et al. (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596-601.
2. Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N, (1991) Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci U S A 88: 5922-5926.
3. Okuno T, Takahashi K, Balachandra K, Shiraki K, Yamanishi K, et al. (1989) Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 27: 651-653.
4. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, et al. (2005) A population-based study of primary human herpesvirus 6 infection. N Engl J Med 352: 768-776.
5. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, et al. (1988) Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1: 1065-1067.
6. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, et al. (1995) Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92: 7440-7444.
7. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, et al. (1997) Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3: 1394-1397.
8. Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM, (2003) Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 187: 1365-1376.
9. Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, et al. (2005) Multiple sclerosis. Immunol Rev 204: 208-231.
10. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, et al. (1999) CD46 is a cellular receptor for human herpesvirus 6. Cell 99: 817-827.
11. Liszewski MK, Kemper C, Price JD, Atkinson JP, (2005) Emerging roles and new functions of CD46. Springer Semin Immunopathol 27: 345-358.
12. Lusso P, Markham PD, Tschachler E, di Marzo Veronese F, Salahuddin SZ, et al. (1988) In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med 167: 1659-1670.
13. Takahashi K, Sonoda S, Higashi K, Kondo T, Takahashi H, et al. (1989) Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol 63: 3161-3163.
14. Banchereau J, Steinman RM, (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
15. Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, et al. (2007) Dendritic cell subsets in health and disease. Immunol Rev 219: 118-142.
16. Suga S, Yoshikawa T, Kajita Y, Ozaki T, Asano Y, (1998) Prospective study of persistence and excretion of human herpesvirus-6 in patients with exanthem subitum and their parents. Pediatrics 102: 900-904.
17. Hirata Y, Kondo K, Yamanishi K, (2001) Human herpesvirus 6 downregulates major histocompatibility complex class I in dendritic cells. J Med Virol 65: 576-583.
18. Kakimoto M, Hasegawa A, Fujita S, Yasukawa M, (2002) Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J Virol 76: 10338-10345.
19. Asada H, Klaus-Kovtun V, Golding H, Katz SI, Blauvelt A, (1999) Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J Virol 73: 4019-4028.
20. Bertelsen LB, Petersen CC, Kofod-Olsen E, Oster B, Hollsberg P, et al. (2010) Human herpesvirus 6B induces phenotypic maturation without IL-10 and IL-12p70 production in dendritic cells. Scand J Immunol 71: 431-439.
21. Takemoto M, Imasawa T, Yamanishi K, Mori Y (2009) Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. Virology.
22. Smith AP, Paolucci C, Di Lullo G, Burastero SE, Santoro F, et al. (2005) Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6. J Virol 79: 2807-2813.
23. Gustafsson RK, Engdahl EE, Fogdell-Hahn A, (2012) Development and validation of a Q-PCR based TCID50 method for human herpesvirus 6. Virol J 9: 311.
24. Reed LJ, Muench H, (1938) A simple method of estimating fifty per cent endpoint. Am J Hyg 27: 493-497.
25. Nitsche A, Muller CW, Radonic A, Landt O, Ellerbrok H, et al. (2001) Human herpesvirus 6A DNA Is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 183: 130-133.
26. Ronni T, Melen K, Malygin A, Julkunen I, (1993) Control of IFN-inducible MxA gene expression in human cells. J Immunol 150: 1715-1726.
27. Holzinger D, Jorns C, Stertz S, Boisson-Dupuis S, Thimme R, et al. (2007) Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 81: 7776-7785.
28. Bertolotto A, Sala A, Caldano M, Capobianco M, Malucchi S, et al. (2007) Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta. J Immunol Methods 321: 19-31.
29. Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, et al. (2011) Direct effects of type I interferons on cells of the immune system. Clin Cancer Res 17: 2619-2627.
30. Jaworska J, Gravel A, Flamand L, (2010) Divergent susceptibilities of human herpesvirus 6 variants to type I interferons. Proc Natl Acad Sci U S A 107: 8369-8374.
31. Atta ur R, Harvey K, Siddiqui RA, (1999) Interleukin-8: An autocrine inflammatory mediator. Curr Pharm Des 5: 241-253.
32. Hickey MJ, Kubes P, (2009) Intravascular immunity: the host-pathogen encounter in blood vessels. Nat Rev Immunol 9: 364-375.
33. Harberts E, Yao K, Wohler JE, Maric D, Ohayon J, et al. (2011) Human herpesvirus-6 entry into the central nervous system through the olfactory pathway. Proc Natl Acad Sci U S A 108: 13734-13739.
34. Murakami Y, Tanimoto K, Fujiwara H, An J, Suemori K, et al. (2010) Human herpesvirus 6 infection impairs Toll-like receptor signaling. Virol J 7: 91.
35. Sullivan BM, Coscoy L, (2008) Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 u24 protein. J Virol 82: 602-608.
36. Zhou L, Chong MM, Littman DR, (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.